logo

EVIDENCE • EXPERIENCE • OUTCOMES

INTELLIGENCE BYMDReviewer
Home
About
Contact
Back
  • No Preview Available

Nalu Neurostimulation System

Write a review
Generic:Stimulator, Spinal-Cord, Implanted (Pain Relief)
Manufacturer:Boston Scientific Neuromodulation
Drug Classes:Not Available
Reps:
Rep 1Signup or Login to view Reps
Rep 2Signup or Login to view Reps
  • No Preview Available

Nalu Neurostimulation System

Generic:Stimulator, Spinal-Cord, Implanted (Pain Relief)
Manufacturer:Boston Scientific Neuromodulation
Drug Classes:Not Available
Reps:
Rep 1Signup or Login to view Reps
Rep 2Signup or Login to view Reps
👋

No reviews yet — be the first!

100% anonymous · Verified U.S. prescribers only

(no name, NPI, or practice ever shown)
Synopsis
Contents
DescriptionIndication and Usage
Similar Products
Synopsis
Generated with AlphaAI.MD
Product:
Nalu Neurostimulation System
Category:
Indication:
Mechanism:
Safety:
Dosing:
Patient:
Reviews:
No reviews yet
see more
Disclaimer: The synopsis and product information provided on Alpha.MD are derived from openFDA data and are for informational purposes only. This information may not be comprehensive, accurate, or up-to-date. Clinicians should exercise their own professional judgment in interpreting and using this information, and consult the official prescribing information for the most accurate and current details.
Description

An implanted spinal cord stimulator for pain relief is a device that is used to stimulate electrically a patient's spinal cord to relieve severe intractable pain. The stimulator consists of an implanted receiver with electrodes that are placed on the patient's spinal cord and an external transmitter for transmitting the stimulating pulses across the patient's skin to the implanted receiver.

Indication and Usage

The Nalu Neurostimulation System is indicated as the sole mitigating agent or as an adjunct to other modes of therapy used in a multidisciplinary approach for chronic, intractable pain of the trunk and/or limbs, including unilateral or bilateral pain. The trial devices are solely used for trial stimulation (no longer thank 30 days) to determine efficacy before recommendation for a permanent (long term) device.

Approval History
FDA approved 2019
Includes history for all formulations of adalimumab
March 22, 2019
(Type 2 New Active Ingredient and Type 4 New Combination)
Frequently Asked Questions
How much does Humira cost without insurance?
J
John Doe
New York, US
Products:

Humira

Humira

J
John Doe
New York, US
Products:

Humira

Humira

Signup or Login to view Reps
You must have an account to view Reps detail
Already have an account? Login
There isn't any reviews posted yet. You can be the first to review the product